Nucleic acid-controlled catalytic rnas for trigger-responsive regulation
US-2024425855-A1 · Dec 26, 2024 · US
Inhibiting migration of cancer cells
US9512425B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9512425-B2 |
| Application number | US-201314437432-A |
| Country | US |
| Kind code | B2 |
| Filing date | Oct 23, 2013 |
| Priority date | Oct 23, 2012 |
| Publication date | Dec 6, 2016 |
| Grant date | Dec 6, 2016 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
As described herein, increased expression of microRNA-708 reduces migration and metastasis of cancer cells.
First claim
Opening claim text (preview).
What is claimed: 1. A method of inhibiting migration of breast cancer cells in an animal comprising systemic or local administration of microRNA-708 to the animal. 2. The method of claim 1 , wherein the microRNA-708 comprises an RNA molecule with natural nucleotides and natural bonds between the nucleotides. 3. The method of claim 1 , wherein the microRNA-708 comprises a nucleic acid with non-natural nucleotides. 4. The…
Assignees
Inventors
Classifications
Chemistry & Metallurgy · mapped topic
Chemistry & Metallurgy · mapped topic
- C12N15/111Primary
Chemistry & Metallurgy · mapped topic
Human Necessities · mapped topic
- C12N15/113Primary
Chemistry & Metallurgy · mapped topic
Patent family
Related publications grouped by family.
External sources
Next steps
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US9512425B2 cover?
- As described herein, increased expression of microRNA-708 reduces migration and metastasis of cancer cells.
- Who is the assignee on this patent?
- Univ Cornell
- What technology area does this patent fall under?
- Primary CPC classification C12N15/111. Mapped technology areas include Chemistry & Metallurgy.
- When was this patent published?
- Publication date Tue Dec 06 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).